scispace - formally typeset
M

Maria Helena Ornellas

Researcher at Rio de Janeiro State University

Publications -  54
Citations -  623

Maria Helena Ornellas is an academic researcher from Rio de Janeiro State University. The author has contributed to research in topics: Biology & Myeloid leukemia. The author has an hindex of 11, co-authored 46 publications receiving 529 citations. Previous affiliations of Maria Helena Ornellas include National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Age-related changes in natural killer cell receptors from childhood through old age

TL;DR: This initial study provides the framework for more focused studies of this subject, which are necessary to determine whether the changing balance of NK receptor expression may influence susceptibility to infectious, inflammatory, and neoplastic diseases.
Journal ArticleDOI

Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia

TL;DR: It seems that some chromosomal alterations may predict the evolution of the disease and are correlated with short survival, as for example the trisomy of chromosome 8, and might be incorporated in the high risk group in the IPSS.
Journal ArticleDOI

Human papillomavirus and penile cancers in Rio de Janeiro, Brazil: HPV typing and clinical features.

TL;DR: HPV infection may have contributed to malignant transformation in a large proportion of penile cancer cases but only inguinal metastasis was a prognostic factor for survival in these patients with penile carcinoma.
Journal ArticleDOI

Monitoring of gas station attendants exposure to benzene, toluene, xylene (BTX) using three-color chromosome painting

TL;DR: Monitoring 60 gas station attendants in Brazil found that 16.6% of the studied population showed elevated frequencies of chromosomal abnormalities, which is highly likely to be correlated with their exposure to BTX during their work.
Journal ArticleDOI

CDKN2A (p14ARF/p16INK4a) and ATM promoter methylation in patients with impalpable breast lesions

TL;DR: The DNA methylation pattern in CDKN2A (p14(ARF)/p16(INK4a)) and in ATM gene promoters are reported and ATM showed the greatest percentage of methylation in DNA from lesions, blood, and saliva, and p16(inks4a) methylation was found in the blood.